Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
In the latest session, Cyclacel Pharmaceuticals Inc (NASDAQ: CYCC) closed at $0.37 down -38.84% from its previous closing price of $0.61. In other words, the price has decreased by -$38.84 from its previous closing price. On the day, 7.33 million shares were traded.
Ratios:
For a deeper understanding of Cyclacel Pharmaceuticals Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.60 and its Current Ratio is at 5.60. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Feb 26 ’25 when Lazar David E. sold 194,628,820 shares for $0.03 per share. The transaction valued at 5,507,996 led to the insider holds 0 shares of the business.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 824.00 while its Price-to-Book (P/B) ratio in mrq is 1.57.
Stock Price History:
Over the past 52 weeks, CYCC has reached a high of $39.84, while it has fallen to a 52-week low of $0.58. The 50-Day Moving Average of the stock is -88.39%, while the 200-Day Moving Average is calculated to be -95.26%.
Shares Statistics:
A total of 12.96M shares are outstanding, with a floating share count of 10.41M. Insiders hold about 53.27% of the company’s shares, while institutions hold 0.46% stake in the company.
